Three-dimensional 1H-magnetic resonance spectroscopy of the prostate in clinical practice: Technique and results in patients with elevated prostate-specific antigen and negative or no previous prostate biopsies

European Radiology

Volumn 15, Issue 4, 2005, Pages 645-652

  Wetter, Axel ^a   Hübner, Frank ^a   Lehnert, Thomas ^a   Fliessbach, Klaus ^b   Vorbuchner, Marianne ^c   Roell, Stefan ^c   Zangos, Stephan ^a   Luboldt, Wolfgang ^a   Vogl, Thomas J ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c SIEMENS AG   (Germany)

Author keywords

MRI; Prostate; Spectroscopy

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; BIOPSY; BLOOD; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

AGED; BIOPSY; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 17044365433     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-004-2562-3     Document Type: Article

References (27)

1. Quinn M, Babb P (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I. International comparisons. Br J Urol Int 90:162-173
2. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2004) Leveling of prostate cancer mortality in Western Europe. Prostate 60:46-52 10.1002/ pros.20058
3. Purohit RS, Shinohara K, Meng MV, Carroll PR (2003) Imaging clinically localized prostate cancer. Urol Clin North Am 30:279-293
4. Sanchez-Chapado M, Angulo JC, Ibarburen C, et al (1997) Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. Eur Urol 32:140-149
5. Ito H, Kamoi K, Yokoyama K, Yamada K, Nishimura T (2003) Visualization of prostate cancer using dynamic contrast-enhanced MRI: Comparison with transrectal power Doppler ultrasound. Br J Radiol 76:617-624 10.1259/bjr/ 52526261
6. Kurhanewicz. J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ (1996) Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7 cm 3) spatial resolution. Radiology 198:795-805
7. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB (2002) Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer (review). J Magn Reson Imaging 16:451-463 10.1002/jmri.10172
8. Hasumi M, Suzuki K, Taketomi A, et al (2003) The combination of multi-voxel MR spectroscopy with MR imaging improves the diagnostic accuracy for localization of prostate cancer. Anticancer Res 23:4223-4227
9. Beyersdorff D, Taupitz M, Winkelmann B, et al (2002) Patients with elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: Value of MR imaging. Radiology 224:701-706 12202702
10. Scheenen TWJ, Klomp DWJ, Röll SA, Fütterer JJ, Barentsz JO, Heerschap A (2004) Fast acquisition-weighted three dimensional proton MR spectroscopic imaging of the human prostate. Magn Reson Med 52:80-88 10.1002/mrm.20103
11. Pohmann R, von Kienlin M (2001) Accurate phosphorus metabolite images of the human heart by 3D acquisition-weighted CSI. Magn Reson Med 45:817-826 10.1002/mrm.1110
12. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R (1998) Simultaneous in vivo spectral editing and water suppression. NMR Biomed 11:266-272 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.3.CO;2-A
13. Zangos S, Eichler K, Engelmann K, et al (2004) MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: Technique and preliminary results. Eur Radiol (Epub ahead of print)
14. Bates TS, Gillatt DA, Cavanagh PM, Speakman M (1997) A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. Br J Urol 79:927-932
15. Boni RA, Hutter BE, Trinkler F, Jochum W, Pestalozzi D, Krestin GP (1996) Preoperative T-staging of prostate carcinoma: Endorectal magnetic resonance tomography compared with other imaging and clinical methods. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 165:152-158
16. Presti JC, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR (1996) Local staging of prostatic carcinoma: Comparison of transrectal sonography and endorectal MR imaging. Am J Roentgenol 166:103-108
17. Ekici S, Ozen H, Agildere M, et al (1999) A comparison of transrectal ultrasonography and endorectal magnetic imaging in the local staging of prostate carcinoma. Br J Urol Int 83:796-800
18. Yu KK, Scheidler J, Hricak H, et al (1999) Prostate cancer: Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481-488 1:STN:280:DC%2BD3c%2FhvV2htQ%3D%3D
19. Engelbrecht MR, Jager GJ, Laheij, RJ, Verbeek ALM, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: A meta-analysis. Eur Radiol 12:2294-2302 12195484
20. Tamada T, Sone T, Nagai K, et al (2004) T2-weighted MR-imaging of prostate cancer: Multishot echo-planar imaging vs fast spin-echo imaging. Eur Radiol 14:318-325 10.1007/s00330-003-2118-y
21. Pegios W, Bentas W, Wittmann L, et al (2003) MRI staging of prostate cancer with the combined endorectal phased-array coil and histologic correlation. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 175:1660-1666 10.1055/s-2003-45325
22. Kuhn M, Huttmann P, Spielhaupter E, Gross-Fengels W, Schreiter F (2001) Clinical value of native and contrast enhanced MRI in staging prostatic carcinoma before planned radical prostatectomy. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 173:595-600 10.1055/s-2001-15839
23. Rouvière O, Raudrant A, Ecochard R, et al (2003) Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13:931-942 12695812
24. Preziosi P, Orlacchio A, Di Giambattista G, et al (2003) Enhancement patterns of prostate cancer in dynamic MRI. Eur Radiol 13:925-930 12695811
25. Schlemmer HP, Merkle J, Grobholz R, et al. (2004) Can preoperative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol 14:309-317 10.1007/s00330-003-2025-2
26. Scheidler J, Hricak H, Vigneron DB, et al (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging: clinicopathologic study. Radiology 213:473-480 1:STN:280:DC%2BD3c%2FhvV2htA%3D%3D
27. Shukla-Dave A, Hricak H, Eberhardt SC, et al (2004) Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings-initial observations. Radiology 231:717-724